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Neural stem cell (NSC) state and fate depend on spatially and temporally synchronized transcriptional and
epigenetic regulation of the expression of extrinsic signaling factors and intrinsic cell-specific genes, but the
functional roles for chromatin-modifying enzymes in neural differentiation remain poorly understood. Here we
show that the histone demethylases KDM4A (JMJD2A) and KDM4C (JMJD2C) are essential for proper
differentiation of NSCs in vitro and in vivo. KDM4A/C were required for neuronal differentiation, survival and
expression of the neurotrophic signaling factor BDNF in association with promoter H3K9 demethylation and
RNA polymerase II recruitment. Unexpectedly, KDM4A/C were essential for selective H3K36 demethylation
and loss of RNA polymerase II recruitment in transcribed regions of the astrocyte-characteristic gene GFAP,
thereby in parallel repressing astrocytic differentiation by control of elongation. We propose that gene- and
lysine-specific KDM4A/C-mediated control of histone methylation and thereby regulation of intrinsic factors
and signaling factors such as BDNF provide a novel control mechanism of lineage decision.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The potential to express cell-specific genes during
differentiation varies significantly among different types
of stem cells and progenitors. These differences have
largely been attributed to distinct epigenetic signatures
and chromatin modifications, including acetylation and
methylation of histones. Eukaryotic gene expression is
strongly influenced by chromatin structure in large part
established through modification of the N-terminal tails
of the histones [1,2]. Histone methylation has been
implicated in both gene activation and repression
depending on the methylation site. Thus, methylation
on lysine 4, lysine 36 and lysine 79 in histone 3 (H3K4,
H3K36 and H3K79) is associated with active transcrip-
tion, while methylation on lysine 9 and lysine 27 in
histone3 (H3K9andH3K27) andon lysine20 in histone
4 (H4K20) is linked to repression of transcription [3].
Although histone methylation was long considered
irreversible, the identification of numerous site-Authors. Published by Elsevier Ltd. This
rg/licenses/by-nc-nd/3.0/).specific lysine demethylases (KDMs) provides com-
pelling evidence that this modification is dynamically
regulated [4–6]. Themajority of KDMs belong to a large
family of Jumonji (JmjC) domain-containing proteins.
Considerable progress has been made toward under-
standing the dynamic regulation of histonemethylation,
whereas less is understood about the biological
functions of these demethylases. Most investigations
have focused so far on demethylase activity in
embryonic stem cells (ESCs) or reprogrammed cells
[7] regulating either H3K4, such as the KDM5 family
[8,9], or H3K27, such as KDM6A (UTX) [10,11]. In
neural development, the H3K27 demethylase KDM6B
(JMJD3) has been shown to activate specific compo-
nents of the program during differentiation of neural
stem cells (NSCs) into GABAergic neurons [2,12], and
the JmjC domain-containing protein KDM7 has been
shown to demethylate monomethylated or dimethy-
lated H3K27, as well as H3K9, with implications for
normal brain development in zebrafish [13].is an open access article under the CC BY-NC-ND license
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demethylate both H3K9me3 and H3K36me3 [14–17].
While H3K9me3 has been generally associated with
transcriptional repression and formation of hetero-
chromatin [1], H3K36me3 is enriched in coding
regions of actively transcribed genes [18], associ-
ated with RNA polymerase II (PolII) recruitment, and
thus to transcriptional elongation [19–21]. The fact
that these proteins can catalyze the demethylation
of both H3K9 and H3K36 seems paradoxical and
suggests multiple cell context-dependent roles for
these enzymes. KDM4C can bind to the androgen
receptor (AR) and work as a coactivator of AR-in-
duced transcription and cellular growth [22]. Alter-
natively, KDM4A has been previously shown to be
associated in complex with the transcriptional
repressor NCoR [23]. NCoR has been shown to
play major roles in development of several organs, for
example, as a major repressor of astrocyte differenti-
ation in NSCs [24], and siRNA-mediated knockdown of
KDM4A indeed leads to an up-regulation of the NCoR
target gene ASCL2 [16]. Both KDM4A/C are over-
expressed in certain types of cancer and their inhibition
affects cellular growth [15,17,25]. In addition, KDM4C
has been implicated together with KDM2A (JMJD1A) in
the regulation of mouse ESCs' self-renewal capacity by
controlling the expression of the transcription factor
Nanog [26], and more recently also KDM4B has been
implicated in the regulation of ESC characteristics [27].
However, the putative roles for H3K9/36 demethylases
in neural differentiation remain unclear.
Here we show that KDM4A/C are required for proper
neuronal differentiation and survival of NSCs by
regulating the expression of essential neuronal and
astrocytic genes associated with demethylation of
H3K9me3 and H3K36me3. By control of H3K9me3 in
the promoter of the neurotrophic signaling factor Bdnf,
KDM4A/C regulated the survival of differentiating
neurons. Unexpectedly, KDM4A/C-mediated control
of intrinsic GFAP expression and astrocyte differenti-
ation in neural progenitors in vivo and in vitro was
selectively associated with the methylation status of
H3K36 and PolII recruitment in transcribed regions
without displaying any changes of histone methylation
in the promoter. Taken together, we propose that this
gene- and lysine-specific novel regulatory mechanism
of histone methylation provides essential control of
proper NSC differentiation and lineage decision.Results
KDM4A and KDM4C knockdown alters NSC
differentiation
As the documented early roles for histone demethy-
lases in ESCs prohibit analysis of conventional
gene-deleted animals, we developed an siRNAstrategy in multipotent FGF2-expanded embryonic
cortical progenitors, also referred to as NSCs to
elucidate possible roles for the H3K9me3 and
H3K36me3 demethylases KDM4A and KDM4C in
neural progenitor differentiation. NSCs isolated from
E15 rat neocortices and expanded in FGF2 self-renew
and differentiate into at least three lineages: neurons
(various subtypes), astrocytes and oligodendrocytes
[12,24,28–30], and experiments in clonal conditions
have confirmed that a single such NSC can give rise to
colonies of both neurons and astrocytes [12,29].
We first cultured NSCs after mitogen withdrawal, a
standard protocol that results in spontaneous differen-
tiation into roughly equal proportions of neurons and
astrocytes [28,31,32], and studied the effects on
neuronal and astrocytic differentiation after knocking
down the expression of KDM4A and/or KDM4C with
the specific siRNAs siKDM4A and siKDM4C (transfec-
tion efficiency of around 70%, see Fig. S1a and b; for
knockdown efficiency, see Fig. S2a and b). Immuno-
cytochemistry revealed that the number of GFAP-po-
sitive cells were significantly increased (N10-fold) when
NSCs were nucleofected with siRNAs against KDM4A
alone or together with KDM4C compared to control,
while we did not observe any significant difference in
the number of TuJ1-positive cells (Fig. S1d).
As mitogen withdrawal results in a relatively slow
and unspecific differentiation process, we next
aimed at investigating putative roles for KDM4A/C
more specifically in neuronal differentiation. Treat-
ment with histone deacetylase inhibitors, such as
valproic acid (VPA), relieves repression specifically
of neuronal differentiation and induces an in-
creased number of neurons without altering astro-
cyte differentiation [33–36]. Furthermore, we and
others have found that VPA-mediated neuronal
differentiation is associated with increased acety-
lation of H3K9 in the promoter of developmental
genes such as BDNF (Ref. [37] and data not
shown). To investigate the role for KDM4A/C in
neuronal differentiation in more depth, we therefore
treated NSCs with VPA after RNA knockdown of
KDM4A and/or KDM4C with the specific siRNAs. In
general, NSCs were transfected with the siR-
NAs ≈ 16 h before VPA treatment. The timepoints
refer to time after administration of VPA. Nucleofec-
tion of siKDM4A and/or siKDM4C resulted in a
significant reduction of the number of TuJ1-positive
cells after 48 h of VPA treatment (Fig. 1a and b). In
parallel, there was a significant increase in the
number of GFAP-positive cells when KDM4A alone or
together with KDM4C was down-regulated (Fig. 1a
and b). Immunoblotting analysis with TuJ1 and GFAP
antibodies showed that the alterations in the number
of positive cells for these markers in each condition
correlated with changes in protein levels (Fig. S1c).
We noted a significant reduction in the number of
total cells in those cultures nucleofected with siKDM4A
alone or together with siKDM4C compared to control
Fig. 1. KDM4A and KDM4C knockdown in embryonic NSCs increases the number of GFAP-positive cells even under
conditions enhancing neuronal differentiation.NSCs isolated from E15.5 rat neocortices were nucleofected with a siControl
or with specific siRNAs against KDM4A and/or KDM4C the day before the experiment and were incubated for 2 days in the
presence of VPA. Cells were collected for RNA extraction after 12 h, 24 h and 48 h of treatment and fixed for
immunofluorescence analysis after 48 h.(a) Immunocytochemistry with TuJ1 antibody (in green) and GFAP antibody (in
red), with DAPI (in blue) counterstaining. Scale bar represents 40 μm.(b) Quantification of the total number of
TuJ1-positive cells and GFAP-positive cells, normalized by the number of DAPI-positive cells.(c) Quantification of the total
number of dividing cells (incorporating BrdU) and dead cells (with pyknotic nuclei).(d and e) qRT-PCR analysis of the
expression of the neuronal markers doublecortin (DCX) and β-tubulin III.(f and g) qRT-PCR analysis of the expression of
the astrocytic markers glial fibrillary acidic protein (GFAP) and S-100β.Data are means + SEM. *p b 0.05.
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VPA (Fig. 1a and data not shown). We therefore
investigated whether these differences were due to
changes in the proliferation rate or in the percentage of
cell death. Analysis of incorporation of the proliferation
marker BrdU showed that there were no significant
alterations in the number of cells in S-phase between
any of the conditions (Fig. 1c and Fig. S1e). In contrast,
quantification of pyknotic nuclei revealed a significant
increase in the number of dead cells in VPA-treated
NSC cultures that had received the siKDM4A alone or
together with siKDM4C (Fig. 1c). Importantly, this
increase in cell death was not observed when cells
were cultured in the presence of vehicle (EtOH) only
(Fig. S1e), suggesting that this event could be
specifically associatedwith the decrease in the number
of TuJ1-positive cells observed in the VPA-treated
cultures.
To further investigate whereas these results were
due to changes in gene expression, we analyzed the
RNA levels of markers of pan-neuronal and astrocytic
differentiation by quantitative real-time polymerase
chain reaction (qRT-PCR). After 24 and 48 h of
treatment, we could observe a significant decrease
in the mRNA levels of neuronal markers such as
doublecortin (DCX) and neuronal β-tubulin 3 (β-tubu-
lin III) upon the knockdown of KDM4A alone or
together with KDM4C compared to control (Fig. 1d
and e). In contrast, there was a stable induction
(N100-fold) in the expression levels of the astrocy-
te-associated genes GFAP and, to some extent, an
increase (≈1.5-fold) expression of S-100β by
siKDM4C alone or together with siKDM4A (Fig. 1f
and g). In summary, these results suggest that
reduction of the levels of KDM4A/Cmarkedly affected
the differentiation process and lineage decision of
NSCs.
KDM4A and KDM4C regulate BDNF expression
and H3K9 methylation in the Bdnf promoter
in NSCs
BDNF is a neurotrophin that plays multiple roles in
regulating differentiation, survival and plasticity of
several different populations of neurons [38,39]. We
have previously noted that VPA treatment leads to a
strong and robust up-regulation of BDNF mRNA
expression already after 3 h associated with a rapid
increase in acetylation of H3K9 at the rat Bdnf IV
promoter (data not shown). A pre-requirement for
increased acetylation of H3K9 is that the residue is
demethylated. We therefore speculated that the
regulation of BDNF expression could be dependent
on H3K9 demethylases such as KDM4A and
KDM4C. We first investigated the levels of BDNF
mRNA during VPA treatment at different time points
by qRT-PCR. In agreement with our previous results,
we observed a rapid up-regulation (4- to 5-fold) of its
expression already after 3 h of treatment, which wassustained up to 48 h (Fig. 2a). Chromatin immuno-
precipitation (ChIP) analysis in NSCs revealed that
both KDM4A and KDM4C were occupying the rat
promoter IV and the exon 5 of the Bdnf gene in VPA
conditions (Fig. 2b). Surprisingly, after 6 h, there was
a decrease (≈35%) in the levels of H3K9me3 at the
promoter region but importantly no changes in the
levels of H3K36me3 in the exonic region (Fig. 2c and
d). Notably, we observed a clear increase (≈3-fold)
in PolII recruitment in the transcribed region of Bdnf
during the VPA treatment despite the unchanged
levels of H3K36me3 (Fig. 2e).
BDNF is an extrinsic signaling factor that primarily
activates TrkB receptors and decreased levels of
secreted BDNF result in increased cell death during
neuronal differentiation [40]. Due to the increased cell
death observed specifically after VPA-induced
neuronal differentiation, we speculated that BDNF
expression would be unchanged or decreased upon
KDM4A/C knockdown in the presence of VPA.
Importantly, the significant and dramatic increase in
BDNF expression observed 3 h after VPA adminis-
tration was completely abolished by pre-administra-
tion of siKDM4A/C (Fig. 2f, compare to Fig. 2a). At this
timepoint, the VPA-mediated decrease in H3K9me3
levels was diminished by siKDM4A/C while no
difference was observed in levels of H3K36me3 in
the Bdnf promoter (Fig. S1c and d). In contrast, once
neuronal differentiation has been initiated at 24 and
48 h, BDNF expression was recovered. These results
suggest that KDM4A/C are required for the increase in
BDNF expression at early timepoints of neuronal
differentiation associated with a demethylation of
H3K9me3at the promoter region. Suchdemethylation
would thus allow regulation byacetylation levels of this
residue.KDM4A andKDM4C regulate GFAP expression by
demethylation of H3K36 at transcribed regions in
association with PolII recruitment
KDM4A has been shown to be able to repress
transcription by interacting with the co-repressor
NCoR [23], which have been previously reported by
us and others to play a key role in controlling the
differentiation of NSCs into astrocytes in vivo and in
vitro [24,41,42], as well as glioblastoma tumor cell
characteristics [43]. As previously described, knock-
down of KDM4A and KDM4C in NSCs upon VPA
treatment led to a significant up-regulation in the
gene expression and protein levels of GFAP (Fig. 1f
and Fig. S1c) and to an increase in the number of
GFAP-positive cells (Fig. 1a and b). NCoR has been
shown to occupy the GFAP gene promoter directly
[12,24,41,42]. We therefore investigated whether the
increased GFAP expression by KDM4A/C knock-
down could be a direct effect. ChIP analysis
confirmed that the GFAP gene indeed was a direct
Fig. 2. BDNF expression is regulated by KDM4A/C and associated with H3K9me3 demethylation at the promoter region
during neuronal differentiation.NSCs isolated from E15.5 rat neocortices were cultured for 2 days in the presence of FGF,
VPA or EtOH. Cells were collected for RNA extraction after 1 h, 3 h, 24 h and 48 h of treatment.(a) qRT-PCR analysis of
the expression of BDNF at different time points (1 h, 3 h, 24 h and 48 h) after initiation of treatment with FGF (black bars)
or VPA (white bars).(b) Chromatin from NSCs cultured in VPA conditions for 3 h was immunoprecipitated with anti-KDM4A
and anti-KDM4C and qPCR-ChIP were performed.(c–e) Chromatin from NSCs cultured in VPA or EtOH conditions for 3 h
and 6 h was immunoprecipitated with anti-H3K9me3 (c), anti-H3K36me3 (d) and anti-RNA polymerase II (e), and
qPCR-ChIP were performed.(f) Analysis by qRT-PCR of the expression of BDNF at different time points in NSCs isolated
from E15.5 rat neocortices, nucleofected with a siControl or with specific siRNAs against KDM4A and/or KDM4C the day
before initiation of VPA treatment and subsequently cultured for up to 2 days in the presence of VPA. Cells were collected
for RNA extraction 1 h, 3 h, 24 h and 48 h after initiation of VPA treatment. In comparison with (a) that displays similar
treatments with VPA but without siRNA treatment, a lack of increase in BDNF expression is noted especially evident after
3 h of VPA treatment. Data are means + SEM. *p b 0.05.
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line with the lack of effects by VPA treatment onGFAP
expression, no major changes in the methylated state
of H3K9 at the GFAP promoter or the levels of
H3K36me3 and PolII at the transcribed exon 8 were
detected (Fig. 3a–c). Next, we compared these resultsto those obtained by stimulation with CNTF, an
interleukin-6- and cardiotrophin-1-related factor that
is known to induce efficient astrocytic differentiation
and GFAP expression in NSCs [24,44]. After 30 h of
CNTF treatment, we found not only a decrease
(≈70%) in the H3K9me3 levels at the GFAP promoter
Fig. 3. Increased GFAP expression is associated with H3K36 methylation at the transcribed regions.(a–c) Chromatin
from NSCs cultured in VPA or EtOH conditions for 12 h, 24 h and 48 h was immunoprecipitated with anti-H3K9me3 (a),
anti-H3K36me3 (b) and anti-RNA PolII (c), and qPCR-ChIP with specific primers were performed.(d–f) Chromatin from
NSCs cultured in the presence of FGF or CNTF for 30 h was immunoprecipitated with anti-H3K9me3 (d), anti-H3K36me3
(e) and anti-RNA PolII (F), and qPCR-ChIP were performed.
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state of theH3K36and of the levels of PolII (≈2-fold) in
the transcribed regions exon 6 andexon8 (Fig. 3e and
f) in line with the induction of GFAP expression by
CNTF.
Importantly, knockdown of KDM4A and KDM4C in
VPA conditions resulted in a complete reversal of the
epigenetic changes, leading VPA treatment to mimic
the chromatin pattern on the GFAP gene observed
upon CNTF treatment at the transcribed but not the
promoter region (Fig. 4a–c). Thus, whereas no
effects on the levels of H3K9me3 and H3K36me3
could be detected in the GFAP promoter (Fig. 4a and
b), KDM4A/C knockdown permitted VPA treatment
to induce a clear increase (≈1.9-fold) in the
methylation state of the H3K36 observed in the 3′
end of the GFAP gene (Fig. 4b) associated with a
significant increase (≈4-fold) in the PolII occupancy
in the same regions and in the promoter (Fig. 4c).
Together, these results show that KDM4A and
KDM4C directly regulate the expression of the
GFAP gene by demethylating H3K36me3 at the
exonic regions during the neuronal differentiation.
In order to assess whether knockdown of KDM4A
and KDM4C had a direct effect on the regulation of
the astrocytic differentiation and GFAP expression in
an in vivo context, we performed in utero electropo-
ration of siKDM4A and siKDM4C or control siRNA in
E14.5 mouse embryos, waited 48 h (until E16.5) and
then analyzed the animals by assessing
GFAP-positive cells by immunohistochemistry. Asthe reproducibility of the region and number of cells
transfected by in utero electroporation is limited, we
focused our analysis on brains that showed efficient
unilateral electroporation in the developing dorsal
telencephalon and diencephalon (n = 5 + 5). This
experiment revealed that 100% of the animals that
received siKDM4A and siKDM4C displayed ectopic
GFAP-positive cells in the forebrain on the electro-
porated side (Fig. 4d), whereas no animal electro-
porated with control siRNA showed any unilateral
difference in GFAP expression (Fig. 4e). Thus,
siRNA targeting KDM4A/C is sufficient to induce
GFAP-positive cells and astrocytic differentiation in
vivo.Discussion
It has become increasingly clear that epigenetic
events in stem cells, such as histone modifications,
regulate transcription and govern cell fate decisions
during development [1,4]. KDM4A and KDM4C have
been described as H3K9- and H3K36-specific
demethylases, but little has been understood about
their physiological functions in neural development.
Here we demonstrate that KDM4A and KDM4C play
important roles in NSCs by controlling expression
and methylation levels of H3K9 and H3K36 at key
developmental genes.
Although the levels of KDM4A/C occupancy were
similar, but not same, on both Bdnf andGFAP genes,
Fig. 4. KDM4A/C regulate H3K36 methylation and GFAP expression in neural progenitors in vitro, and KDM4A/C
knockdown induces GFAP expression in vivo.(a–c) Chromatin from NSCs nucleofected with siControl or siKDM4A and
siKDM4C (siJMJDs) and the next day cultured for 24 h in the presence of VPA was immunoprecipitated with
anti-H3K9me3 (a), anti-H3K36me3 (b) and anti-RNA polymerase II (c), and qPCR-ChIP with specific primers were
performed. Data are means + SEM.(d) Developing lateral ventricles from E14.5 mouse embryos were injected with a GFP
plasmid together with either the siControl or the combination of siKDM4A and siKDM4C and subsequently electroporated.
Two days later, embryonic brains were collected and sectioned, and immunohistochemistry analysis was performed.
Aberrant GFAP-positive cells were detected by GFAP antibody (in red) only after electroporation of siKDM4A + siKDM4C,
and DAPI (in blue) was used for counterstaining. Scale bar represents 80 μm.
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of H3K9me3 and H3K36me3 in the promoter and
transcribed regions in accordance with their levels of
transcription during neuronal differentiation. These
differences illustrate the complexity of epigenetic
regulation of gene expression and suggest that the
activity of the KDM4A/C proteins may be dictated by
their binding partners, as previously demonstrated for
KDM1 (LSD1) [45]. When associated with the
repressive CoREST complex, KDM1 acts as a H3K4
demethylase [45]. In contrast, when it formsa complex
with AR, it functions as a transcriptional coactivator,
demethylating H3K9 [46]. It is tempting to speculate
that similar modes of regulation occur also in the case
of KDM4A and KDM4C, and it is of immediate interest
to investigate whether KDM4A (and/or KDM4C) act in
a complex with NCoR to repress astrocyte differenti-
ation. It should further be noted that the relativeexpression of KDM4A and KDM4C was different in
differentiating neurons versus differentiating astro-
cytes (Figs. S1e, S2 and S3), further pointing to
functional specificity between the two enzymes.
Future studies of genome wide occupancy of the
two factors in multiple specific cell types should bring
some light on these issues. Another degree of
complexity resides in the spatial distribution of the
methylated lysines, since certain methyl marks can
have multiple functions in the cell, depending on
where they are; for example, H3K9me3 is clearly
linked to transcriptional repression when located at
promoter regions, but it is also enriched within coding
regions of actively transcribed genes [47,48].
In contrast to ESCs, less is known about the role
for chromatin-modifying proteins in multipotent pro-
genitors, such as NSCs. It has been shown that a
PcG-mediated epigenetic mechanism plays a pivotal
3474 Gene-Specific Demethylation of H3K9/H3K36me3 in Neural Progenitorsrole in driving the transition from the neurogenic phase
to the astrogenic phase during mouse neocortical
development by silencing the ngn1 locus in NSCs
[49]. Additionally, we and others have previously
demonstrated a critical mechanism that regulates the
timing of astrogenesis in NSCs through the NCoR
repressive complex [24]. In contrast to wild-type
NSCs, a large number of NCoR−/− cells exhibit an
astroglial-like morphology and express GFAP. Inter-
estingly, KDM4A interacts with the NCoR complex
and it has been proposed to function as a transcrip-
tional repressor [16,23]. This is in line with the present
study where loss of KDM4A/C mediated an increase
in GFAP expression. It is yet surprising that this
increase in GFAP expression correlated with in-
creased H3K36me3 in transcribed regions and RNA
polymerase II recruitment in transcribed regions, as
well as the promoter, and not with an effect on
H3K9me3 in the GFAP promoter. This result makes it
tempting to speculate whether chromatin modifica-
tions in the transcribed regions are sufficient for RNA
PolII recruitment to the promoter. The discrepancy
further highlights the importance of understanding in
which cellular context and protein complexes these
demethylases are acting and suggests that spatial
and temporal differences in nuclear nanoarchitecture
must be taken into account when assessing the
potential of geneexpression inmultipotent progenitors
during development.Materials and Methods
NSC cultures
Embryonic NSCs were derived as previously described
[12,24,30]. Rat cortical tissue from embryonic day 15.5
was dissociated and 800 × 103 cells were plated per
10-cm dish, previously coated with poly-L-ornithine and
fibronectin (both Sigma-Aldrich). NSCs were expanded in
N2 media with 10 ng/ml of basic fibroblastic growth factor
(R&D Systems). For neuronal differentiation assays, NSCs
were plated in the absence of FGF2 (N2) and in the
presence of 1 mM VPA (Sigma-Aldrich). We used 70%
ethanol (vehicle) as negative control. Treatments were
added daily and media was changed every second day.
For astrocytic differentiation assays, NSCs received
recombinant CNTF (R&D Systems) at 10 ng/ml for 24 h.
Then CNTF was added again at the same concentration
for 6 h more before cells were harvested. Animals were
treated in accordance with institutional and national
guidelines (Stockholms Norra Djurförsöksetiskanämnd).
Nucleofections and siRNAs
siRNAs nucleofections were performed according to the
supplier's recommendations (Rat NSC Kit, program A-33;
Lonza). We used 4 μg of siRNA and 3 × 106 to 4 × 106
cells for each nucleofection. In general, NSCs were
transfected with the siRNAs ≈ 16 h before treatment andcultured in the presence of FGF2. Cells were collected for
immunocytochemistry, qRT-PCR or ChIP analysis at the
time points stated. Target sequences for siRNAs:
ECFP control: 5′-GAAGAACGGCAUCAAGGCC-3′, (A4
synthesis, Dharmacon)
KDM4A: 5 ′-GAGCAGAUGUGAAUGGUACUCUCUA-3 ′
(Invitrogen)
KDM4C: 5 ′-CCAGAGCAUGGAAAGCGACUUGAAA-3 ′
(Invitrogen)
Similar results were obtained with two alternative
siRNAs specifically targeting KDM4A and KDM4C (se-
quences available upon request).
Immunocytochemistry and cell quantification
Cells were fixed in 10% formalin for 20 min and washed
in phosphate-buffered saline (PBS) (with 0.1% Triton
X-100; PBS-TX), 3 × 5 min. After an overnight incubation
at 4 ºC with the primary antibodies, α-TuJ1 (Biosite
MMS435P, 1:500) and α-GFAP (DakoCytomation Z0334,
1:500), in PBS-TX with 1–3% bovine serum albumin
(BSA), cells were washed 6 × 5 min with PBS-TX,
followed by 1 h incubation at room temperature with
secondary antibody (donkey or goat anti-mouse and
anti-rabbit conjugated to Alexa 488 or Alexa 594;
Molecular Probes/Invitrogen, 1:500) in PBS-TX with 1%
BSA. After three washes with PBS, cells were counter-
stained with 4′,6-diamidino-2-phenylindole (DAPI; Vector
Laboratories). Images were acquired with a Zeiss Axios-
kop 2 microscope and collected with a Zeiss AxioCam
camera MRm (with Axiovison Rel 4.6 software). Quantita-
tive immunocytochemical data of NSC cultures represent
means ± SEM (standard error of the mean) obtained from
5–7 non-overlapping 20× fields in each condition, from
four separate independent experiments, after normaliza-
tion with the number of DAPI-positive cells present in the
same fields. For BrdU assay, NSCs were nucleofected
with siKDM4A and/or siKDM4C or siECFP control and
treated for 48 h with 70% EtOH or VPA. Cells were then
exposed to a 4 μMBrdU concentration for 2 h and followed
by immunocytochemical analysis of BrdU incorporation,
using a primary antibody rat α-BrdU (Abcam, ab6326,
1:1000). Quantitative immunocytochemical data of NSC
cultures represent means ± SEM obtained from 5–7
non-overlapping 10× fields in each condition, from three
separate independent experiments, after normalization
with the number of DAPI-positive cells present in the same
fields. For DAPI quantification, a macro was programmed
in Image J. Pyknotic nuclei and viable cell nuclei were
counted by defining nuclei as being N20 pixels and viable
nuclei being N70 pixels on 10× fields.
Immunoblotting
Cells were rinsed twice with cold PBS, collected by
scraping and pelleted at 1000 rpm for 2 min at 4 °C. Cells
were then resuspended in SDS lysis buffer [25 mM Tris–
HCl (pH 7.5), 1% SDS, 1 mM ethylenediaminetetraacetic
acid, 20 mM sodium orto-vanadate, 20 mM β-glycerolpho-
sphate, 30 mM sodium pirophosphate and cocktail prote-
ase inhibitors], boiled 20 min and centrifuged at
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were collected and protein concentration measured. We
mixed 20 μg of protein with loading buffer containing SDS,
glycerol, β-mercaptoethanol and DTT and run it in an 8%
sodium dodecyl sulfate-polyacrylamide gel. After electro-
phoresis, samples were transferred onto nitrocellulose
membranes (BioRad) and blocked with 5% skim milk in
PBS plus 0.1% Tween 20 (PBS-T). Membranes were
incubated with primary antibodies in blocking buffer
overnight at 4 °C. After being washed with PBS-T,
membranes were incubated for 1 h at room temperature
with horseradish-peroxidase-conjugated secondary anti-
bodies (Chemicon, 1:2000) in 5% skim milk in PBS-T and
then washed again with PBS-T. Blots were developed
using RPN2106 ECL Western blotting detection reagents,
from GE Healthcare. The following antibodies were used
as primary antibodies: α-TuJ1 (Biosite MMS435P, 1:1000),
α-GFAP (Cell Signaling, 3670, 1:1000) and α/β-actin
(Sigma, A5441, 1:2000).
Immunohistochemistry
Frozen sections were thawed 10 min at 37 °C. After two
washes with PBS, sections were blocked for 1 h at room
temperature with blocking solution (PBS with 5% goat
serum, 2%BSA and 0.2% Triton X-100). Primary antibodies
were incubated at 4 °C overnight: α-GFP (Chemicon, 1:500)
and α-GFAP (DakoCytomation, Z0334, 1:500). Following
2 × 10 min washes with PBS, we incubated sections with
secondary antibodies (goat anti-chicken and goat anti-rabbit
555 conjugated to Alexa 488 or Alexa 594; Molecular
Probes/Invitrogen, 1:500) for 1 h at room temperature in
blocking solution. After 3 × 10 min washes, sections were
counterstained with DAPI (Sigma-Aldrich, 1:10,000),
washed twice with PBS, mounted in Dako Fluorescent
mounting medium and visualized in an AxioImager 2
microscope (Zeiss). Images were collected using a Hama-
matsu high-resolution digital camera (ORCA-R2) with
Volocity software (Improvision).Reverse transcription
Total RNA was isolated from NSCs using RNeasy
extraction kit (Qiagen), with DNase treatment in-column.
We used 300 ng of total RNA with the High-Capacity
cDNA Reverse Transcription Kit (Applied Biosystems),
according to the manufacturer's instructions and with each
sample being equally divided in two tubes, a cDNA
reaction tube and a negative control tube (RT−). Before
quantitative PCR (qPCR) analysis, both cDNA and RT−
were then diluted 20× or 10×, respectively, in DNase and
RNase free dH2O (Invitrogen).qPCR and primer design
qRT-PCR reactions were performed in triplicates for
each sample. Each PCR reaction had a final volume of
25 μl and 5 μl of diluted cDNA. RT− was run to discard
genomic DNA amplification. Platinum Quantitative PCR
SuperMix UDG (Invitrogen) was used, according to the
manufacturer's instructions (but with a 4× dilution from the
original master mix). The following thermo cycling programwas used: 50 °C for 2 min, 94 °C for 2 min and then
40 cycles of 94 ° C for 30 s, 59/60 ºC for 30 s and 72 °C
for 30 s on the ABI PRISM 7000 Detection System
(Applied Biosystems). A melting curve was obtained for
each PCR product after each run, in order to confirm that
the SYBR Green signal corresponded to a unique and
specific amplicon. Standard curves were generated for
every RT-PCR run and were obtained by using serial 3-fold
dilutions of a sample containing the sequence of interest.
The Tata binding protein was used as housekeeping gene.
All data are representative results obtained from at least
four independent experiments. GenBank cDNA se-
quences or conserved regulatory sequences identified in
ECR browser were used to design gene-specific primers in
the Universal Probe Library Assay Design Center (Roche
Applied Science). The specificity of PCR primers was
determined by BLAST run of the primer sequences. All
primers were purchased from MWG Biotech. Primer
sequences can be given upon request.
Chromatin immunoprecipitation
ChIP-IT™ Express Kit (Active Motif) was used according
to the supplier's recommendations. Cells were cross-linked
using 1% formaldehyde for 10 min. Cells were rinsed twice
with cold PBS, collected by scraping and pelleted at
2000 rpm for 4 min at 4 °C. Frozen pellets were resuspend-
ed in lysis buffer, centrifuged for 10 min at 4 °C and the
pelleted nuclei were resuspended in shearing buffer.
Chromatin was then sonicated using a Bioruptor™ 200
(Diagenode), high frequency, 0.5 min/0.5 min, for 12 min.
Sonicated chromatin was analyzed in a 1% agarose gel, to
confirm efficient sonication. Input was collected for further
analysis.We incubated 5 μg of chromatin for 1 h at 4 °Cwith
the following antibodies: α-H3K9me3 (Abcam, ab8898,
5 μg), α-H3K36me3 (Abcam, ab9050, 5 μg), α-Ser2P-RNA
polymerase II (Abcam, ab5095, 5 μg), α-Ser5P-RNA
polymerase II (Abcam, ab5131, 5 μg), α-JMJD2A/KDM4A
(Abcam, ab24545), α-JMJD2C/KDM4C (kind gift from Dr.
Ng), histone H3 (Abcam, ab1791, 4 μg) and rabbit IgG
(active motif, negative control, 2 μg), and then immunopre-
cipitated it overnight at 4 °C with protein G magnetic beads.
After 3 + 2 washes with ChIP buffer 1 + 2, the cross-linked
was reversed and DNA was resuspended in a final volume
of 130 μl. Purified DNA and 1% input were analyzed by
qPCR, using 5-fold dilutions of the input for standard curves
and triplicates per sample. All data are representative results
obtained from 2–3 independent experiments.In utero electroporation
In utero electroporation was performed largely as
previously described [44]. CD1 pregnant mice were
deeply anesthetized with isoflurane, a midline incision
was performed and about 1 μl of DNA solution was
injected into E14.5 lateral ventricle. The solution con-
tained a mix of either a nuclear GFP expression plasmid
driven from the EF1 promoter or a CMV-driven EGFP
tracing plasmid (3–5 mg/ml) along with 20 pmol of either
control siRNA (siECFP) or a mix of KDM4A and KDM4C
siRNAs (siJMJDs) and 0.05% Fast Green as a tracer.
After injection, electroporation was performed using a
square electroporator CUY21 EDIT (TR Tech, Japan) to
3476 Gene-Specific Demethylation of H3K9/H3K36me3 in Neural Progenitorsdeliver five 50-ms pulses of 50 Vwith 950 ms intervals per
embryo. Embryonic brains were subsequently harvested
2 days later, fixed in 4% PFA at 4 ºC overnight,
cryoprotected in 30% sucrose at 4 ºC overnight and
embedded in OCT compound (Tissue-Tek). Brains were
kept at −80 ºC until cryosectioned coronally at 20 μm.
Sections were collected on microscope slides and stored
at −80 °C.
Statistical analysis
Statistical analysis and graphs were performed using
the software Prism 4 (GraphPad). When two groups were
compared, statistical analysis was performed using
two-tailed unpaired t-test. When repeated measure-
ments taken at different time points from two groups
were compared, two-way ANOVA analysis of variance
was used. The threshold value for statistical significance
(α value) was set at 0.05 (*p b 0.05). Data are presented
as the means ± SEM of independent experiments.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jmb.2014.04.008.Acknowledgements
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